Beijing Sciecure
Pharmaceutical Co., Ltd. was established in April 2002 and re-structured
its
equity in 2007. The company formed a R&D laboratory in New Jersey,
USA in 2012, and the
business offices in USA in 2013, UK and Canada in
2014.
The campus at
Beijing site,with more than 400 employees and covering 94,000㎡, is a
national
high tech pharmaceutical enterprise with the innovation strategy of
new technology, new products
and new process, and was awarded as High-Tech
Corporation by Beijing Municipal committee of
Science and
Technology.
Since the
first day, Beijing Sciecure Pharmaceutical Co., Ltd. has been collaborated with
many
universities and research institutes, such as Peking University,
Tsinghua University, Beijing
University of Chemical Technology, Institute of
Materia Medica of Chinese Academy of Medical
Sciences, Shenyang
Pharmaceutical University, Academy of Military Medical Sciences, etc.,
to
form the unity of the research, teaching, and manufacturing. Company has
now five innovative
drugs with about 30patentsas well as other 50 more either
new drugs or generic drugs under
the development.
Beijing
Sciecure Pharmaceutical Co., Ltd. now has the advanced facilities of ampoules,
vials for injection, OSD, lyophilization, LVP, and API. All production lines
are designed with the
CFDA, US FDA, and EU GMP philosophy and operated with
the automatic control systems, such
as MES, SCADA, DCS,PLC, and BMS, etc.Our
production lines, warehouse, R&D and
QC laboratories have been installed
by the state-of-the-art instruments/equipmentfor daily
operation.
Sciecure
understands that only high level of quality and service are accepted. Company
recruits
and retains a globalized management team with GMP and R&D
experience.